Metabolite details
Reactome pathways
- No Reactome pathways listed for this metabolite.
Observed in studies
- Hfq Regulates Efflux Pump Expression and Purine Metabolic Pathway to Increase the Trimethoprim Resistance in Aeromonas veronii
- Large-Scale Plasma Analysis Revealed New Mechanisms and Molecules Associated with the Host Response to SARS-CoV-2.
- Metabolic Dynamics of In Vitro CD8+ T Cell Activation.
- Multi-Omics Analysis Reveals Disturbance of Nanosecond Pulsed Electric Field in the Serum Metabolic Spectrum and Gut Microbiota
- High complexity and diel dynamics of planktonic microbiome revealed by multi-omics in Taihu, China
- Gut microbiota production of trimethyl-5-aminovaleric acid reduces fatty acid oxidation and accelerates cardiac hypertrophy
- Distinct succinate modifying products are clinically diagnostic and prognostic biomarkers for fumarate hydratase deficient renal cell carcinoma
- Diallyl disulfide (DADS) ameliorates intestinal Candida albicans infection by modulating the gut microbiota and metabolites and providing intestinal protection in mice
- <i>Pseudomonas</i> sp. Strain 273 Incorporates Organofluorine into the Lipid Bilayer during Growth with Fluorinated Alkanes
- Lipidomic Changes in the Liver of Beagle Dogs Associated with Toxocara canis Infection
- Intergenerational Association of Gut Microbiota and Metabolism between Perinatal Folic Acid Metabolism and Neural Tube Defects (Feces metabolomics)
- Interaction between Cervical Microbiota and Host Gene Regulation in Caesarean Section Scar Diverticulum
- Mechanism of interventional effect and targets of Zhuyu Pill in regulating and suppressing colitis and cholestasis
- Transcriptomic dynamics control rapid transition of core crop functions in 'lactating' pigeon
- Transcript variants of long-chain acyl-CoA synthase 1 have distinct roles in sheep lipid metabolism
Observed in differential profiles
- Wild_type_vs_hfq
- Wild_type_vs_hfq
- non_COVID_19_healthy_vs_non_critical_COVID_19
- non_COVID_19_healthy_vs_non_critical_COVID_19
- G3_Experimental_Sample_0h_vs_G11_Experimental_Sample_96h
- Control_vs_nsPEF_7_day
- Control_vs_nsPEF_7_day
- 2:00 AM_Membrane_vs_2:00 AM_Net
- Wild_Type_vs_TMAVA_Treatment
- Wild_Type_vs_TMAVA_Treatment
- Normal_control_no_tumor_vs_FH_deficient_RCC
- G1_PBS_vs_G2_DSS
- Decane_vs_Difluorodecane
- Control_12h_vs_Toxocara canis_12h
- Normal_vs_Neural_Tube_Defect
- Control_vs_CSD
- Control_vs_ZYP_High_Dose
- Male_19_days_vs_Male_1_day
- Knockdown_vs_Control
- Knockdown_vs_Control